Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Kaken Pharmaceutical
(4521.TSE) Q1 2026
Earnings
4521.TSE
Feb 6
Confirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-139
-85
-30
25
Details
Expected EPS
25
Actual EPS
11
Surprise EPS
-14
Surprise Percent
-56.8%
Description
Kaken Pharmaceutical (4521.TSE) has reported earnings of 11 per share for Q1 2026.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login